1. New managing editor

   • Rune Dahlqvist

   Editorial 30 May 2009 Pages: 649 - 649

2. The pharmacokinetics of codeine and its metabolites in Blacks with sickle cell disease

   • Stacy S. Shord
   • Larisa H. Cavallari
   • Robert E. Molokie

   Clinical Trial 09 April 2009 Pages: 651 - 658

   

3. The impact of everolimus versus mycophenolate on blood and lymphocyte cyclosporine exposure in heart-transplant recipients

   • Finn Gustafsson
   • David Barth
   • Heather J. Ross

   Clinical Trial 21 May 2009 Pages: 659 - 665

   

4. Influence of pharmacogenetics on indinavir disposition and short-term response in HIV patients initiating HAART

   • Julie Bertrand
   • Jean-Marc Treluyer
   • the COPHAR2-ANRS 111 Study Group

   Special Article 14 May 2009 Pages: 667 - 678

   

5. Association of the DRD2 and DRD3 polymorphisms with response to pramipexole in Parkinson’s disease patients

   • Ying-Zi Liu
   • Bei-Sha Tang
   • Hong-Hao Zhou

   Pharmacodynamics 25 April 2009 Pages: 679 - 683

6. Genetic and pharmacokinetic factors affecting the initial pharmacotherapeutic effect of paroxetine in Japanese patients with panic disorder

   • Yoshinori Saeki
   • Takashi Watanabe
   • Kazutaka Shimoda

   Pharmacogenetics 04 March 2009 Pages: 685 - 691

   

7. CYP2C19 genotype is associated with symptomatic recurrence of GERD during maintenance therapy with low-dose lansoprazole

   • Takahisa Furuta
   • Mitsushige Sugimoto
   • Akira Hishida

   Pharmacogenetics 04 March 2009 Pages: 693 - 698

   

8. Effect of smoking and CYP2D6 polymorphisms on the extent of fluvoxamine–alprazolam interaction in patients with psychosomatic disease

   • Hideyo Sugahara
   • Chiharu Maebara
   • Yasufumi Sawada

   Pharmacokinectics and Disposition 19 February 2009 Pages: 699 - 704

   

9. Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis

   • Catherine M. T. Sherwin
   • Sofia Svahn
   • David M. Reith

   Pharmacokinetics and Disposition 21 March 2009 Pages: 705 - 713

   

10. Antidepressant use and mortality in Finland: a register-linkage study from a nationwide cohort

    • Jari Haukka
    • Martti Arffman
    • Ilmo Keskimäki

    Pharmacoepidemiology and Prescription 05 March 2009 Pages: 715 - 720

    

11. Regional surveillance of emergency-department visits for outpatient adverse drug events

    • A. Capuano
    • A. Irpino
    • F. Rossi

    Pharmacoepidemiology and Prescription 18 March 2009 Pages: 721 - 728

    

12. A web-based quantitative signal detection system on adverse drug reaction in China

    • Chanjuan Li
    • Jielai Xia
    • Guanquan Chen

    Pharmacoepidemiology and Prescription 05 March 2009 Pages: 729 - 741

    

13. Drug interactions between inhaled corticosteroids and enzymatic inhibitors

    • Amélie Daveluy
    • Cécile Raignoux
    • Mathieu Molimard

    Letter to the Editors 28 April 2009 Pages: 743 - 745